Ortho Innovation Talks provides an in-depth exploration of the orthopedic industry. We dive into its origins, future prospects, and present-day challenges and opportunities, all from the viewpoint of the industry's top orthopedic companies.
In Season 2, we feature emerging leader Enovis. We explore hip, knee, shoulder, and elbow reconstructive joint surgeries, bracing and supports, foot and ankle solutions, ASCs, and digital health technology all from the viewpoint of Enovis's senior leadership.
In Season 1, Zimmer Biomet provides an in-depth exploration of the orthopedic industry. We dive into its origins, future prospects, and present-day challenges and opportunities, all from the viewpoint of Zimmer Biomet’s senior leadership.
All content for Ortho Innovation Talks: Enovis & Zimmer Biomet is the property of DeviceTalks Podcast Network and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Ortho Innovation Talks provides an in-depth exploration of the orthopedic industry. We dive into its origins, future prospects, and present-day challenges and opportunities, all from the viewpoint of the industry's top orthopedic companies.
In Season 2, we feature emerging leader Enovis. We explore hip, knee, shoulder, and elbow reconstructive joint surgeries, bracing and supports, foot and ankle solutions, ASCs, and digital health technology all from the viewpoint of Enovis's senior leadership.
In Season 1, Zimmer Biomet provides an in-depth exploration of the orthopedic industry. We dive into its origins, future prospects, and present-day challenges and opportunities, all from the viewpoint of Zimmer Biomet’s senior leadership.
S1 E1 - Zimmer Biomet's Rachel Ellingson on driving growth through portfolio shifts and M&A
Ortho Innovation Talks: Enovis & Zimmer Biomet
44 minutes 47 seconds
1 year ago
S1 E1 - Zimmer Biomet's Rachel Ellingson on driving growth through portfolio shifts and M&A
In the inaugural episode of Ortho Innovation Talks: Zimmer Biomet, Rachel Ellingson, SVP and Chief Strategy Officer at Zimmer Biomet, shares insights into the company's growth strategy, emphasizing that growth can be achieved not only through addition - like innovation and acquisition - but also through subtraction, such as exiting lower growth, non-core businesses.
In the episode, Ellingson discusses the decision to spin off Zimmer Biomet's spine and dental businesses and the significant undertaking required to create a new public company, which required integrating and then disintegrating business segments, building corporate infrastructure, and establishing a dedicated leadership team for the new entity - a major initiative involving over 500 people and a dedicated separation management office.
Lastly, Ellingson discusses what's next in Zimmer Biomet's growth strategy, citing a balance between internal innovation and M&A and noting that the company plans to launch over 40 new products in the next 36 months, focusing on markets with at least 4% growth.
Thank you to our episode sponsor, AcuityMD for supporting this podcast. To learn more about AcuityMD, please visit http://acuitymd.com.
***
Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe
Thank you for supporting Ortho Innovation Talks!
Ortho Innovation Talks: Enovis & Zimmer Biomet
Ortho Innovation Talks provides an in-depth exploration of the orthopedic industry. We dive into its origins, future prospects, and present-day challenges and opportunities, all from the viewpoint of the industry's top orthopedic companies.
In Season 2, we feature emerging leader Enovis. We explore hip, knee, shoulder, and elbow reconstructive joint surgeries, bracing and supports, foot and ankle solutions, ASCs, and digital health technology all from the viewpoint of Enovis's senior leadership.
In Season 1, Zimmer Biomet provides an in-depth exploration of the orthopedic industry. We dive into its origins, future prospects, and present-day challenges and opportunities, all from the viewpoint of Zimmer Biomet’s senior leadership.
